Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma. Issue 11 (20th January 2020)

• Record Type: Journal Article
• Authors: Wang, Chongchong; Cheng, Li; Song, Shasha; Wu, Shan; Sun, Guoping
• Is Part Of: Journal of cellular physiology. Volume 235:Issue 11(2020:Nov.)
• Page Start: 8224
• Page End: 8235
• Publication Date: 2020-01-20
• Subjects: esophageal squamous cell carcinoma -- Gli1 -- tumorigenesis -- YAP1; Physiology -- Periodicals; Cell physiology -- Periodicals; 571.6
• DOI: 10.1002/jcp.29477
• Languages: English
• ISSNs: 0021-9541

Abstract

Abstract: Esophageal squamous cell carcinoma (ESCC) is the predominant esophageal cancer type in China. The aberrant activation of glioma‐associated oncogene homolog1 (Gli1), a key factor in Hedgehog (Hh) signaling pathway, has been found in esophageal carcinoma. Moreover, Yes‐associated protein 1 (YAP1), the major mediator of Hippo signaling pathway, has been linked to esophageal carcinoma progression. However, the precise roles and the underlying mechanism of both Gli1 and YAP1 in ESCC are unclear. Here, we found that Gli1 and YAP1 are overexpressed in ESCC and are associated with poor prognosis. In addition, we confirmed that knockdown of Gli1 or YAP1 suppresses ESCC cell growth, migration, and invasion in ESCC TE1 and EC109 cells. Significantly, Gli1 interacts with YAP1 in ESCC cells. Both Gli1 and YAP1 proteins are closely correlated with each other in human ESCC samples. Mechanistically, Gli1 upregulates YAP1 in a LATS1‐independent manner. Conversely, YAP1 induces Gli1 by regulating phosphoinositide 3‐kinase (PI3K)/AKT signaling pathway. Most importantly, we demonstrated that the interaction between Gli1 and YAP1 promotes ESCC tumor growth in vitro and in vivo. Our findings established a novel signaling mechanism by which the interaction between Gli1 and YAP1 promotes ESCC cell growth. This signaling regulation of the tumorigenesis provides a new therapeutic strategy for highly lethal ESCC. Abstract : Our findings established a novel signaling mechanism by which the interaction between glioma‐associated oncogene homolog1 (Gli1) and Yes‐associated protein 1 (YAP1) promotes esophageal squamous cell carcinoma (ESCC) cell growth. This signaling regulation of the tumorigenesis provides a new therapeutic strategy for highly lethal ESCC.